Alisha Mavis
Pediatric Transplant Hepatology · Charlotte, NCNPI 1053583823
Payments from drug & device makers
Across 364 payments — averaging $1298.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Albireo Pharma, Inc.$150K
- Mirum Pharmaceuticals, Inc.$147K
- Ipsen Biopharmaceuticals, Inc$121K
- AstraZeneca$40K
- Sanofi$7K
- Echosens North America, Inc.$6K
- plus $1K from 3 others
What the payments were for
- Consulting fees$162,98041%
- Speaking & faculty fees$173,17243%
- Travel & lodging$54,59214%
- Food & beverage$7,6782%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Albireo Pharma, Inc. | 56 | $150,197 |
| Mirum Pharmaceuticals, Inc. | 176 | $146,852 |
| Ipsen Biopharmaceuticals, Inc | 64 | $121,428 |
| AstraZeneca | 49 | $39,816 |
| Sanofi | 3 | $7,035 |
| Echosens North America, Inc. | 6 | $6,178 |
| Ipsen Pharma SAS | 1 | $960 |
| Intercept Pharmaceuticals, Inc. | 1 | $125 |
| Travere Therapeutics, Inc. | 8 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric transplant hepatology providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.